Nanomedicine is one of the most promising therapeutic modalities researchers are working
on. It involves development of drugs and devices that work at the nanoscale (10–9 m) …

Atherosclerosis is the major cause of heart attack and stroke that are the leading causes of
death in the world. Nanomedicine is a powerful tool that can be engineered to target …

Nanocarriers have drastically changed the face of health care by making a mark in diverse
arenas of diagnosis, drug delivery, and gene delivery to name a few. The recent feat in …

Nanomedicine plays a vital role in targeting therapeutics to the desired site of action. Over
the years, several nanomedicines, like monoclonal antibodies (Rituximab, Brentuximab …

Owing to the inherent shortcomings of traditional therapeutic drugs in terms of inadequate
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …

This handbook (55 chapters) provides a comprehensive roadmap of basic research in
nanomedicine as well as clinical applications. However, unlike other texts in nanomedicine …

Cardiovascular diseases (CVDs) refer to a collection of conditions characterized by
abnormalities in the cardiovascular system. They are a global problem and one of the …

The adult myocardium has a limited regenerative capacity following heart injury, and the lost
cells are primarily replaced by fibrotic scar tissue. Suboptimal efficiency of current clinical …

Atherosclerosis is a typical chronic inflammatory vascular disease that seriously endangers
human health. At present, oral lipid‐lowering or anti‐inflammatory drugs are clinically used …

With the extraordinary advances in nanotechnology, nanomedicine, the application of
nanotechnology in the medical field, has made tremendous progress over the past three …